Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection.

Reed JL, Welliver TP, Sims GP, McKinney L, Velozo L, Avendano L, Hintz K, Luma J, Coyle AJ, Welliver RC Sr.

J Infect Dis. 2009 Apr 15;199(8):1128-38. doi: 10.1086/597386.

PMID:
19278337
2.

Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF.

McNamara PS, Fonceca AM, Howarth D, Correia JB, Slupsky JR, Trinick RE, Al Turaiki W, Smyth RL, Flanagan BF.

Thorax. 2013 Jan;68(1):76-81. doi: 10.1136/thoraxjnl-2012-202288. Epub 2012 Sep 21.

PMID:
23002173
3.

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.

Welliver TP, Reed JL, Welliver RC Sr.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S92-6. doi: 10.1097/INF.0b013e318168b706.

PMID:
18820587
4.

Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.

Tasker L, Lindsay RW, Clarke BT, Cochrane DW, Hou S.

Clin Exp Immunol. 2008 Aug;153(2):277-88. doi: 10.1111/j.1365-2249.2008.03591.x. Epub 2008 Jun 28.

5.

Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.

Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF, Foster PS, Matthaei KI.

Blood. 2007 Sep 1;110(5):1578-86. Epub 2007 May 10.

6.

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.

Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC Sr.

J Infect Dis. 2007 Apr 15;195(8):1126-36. Epub 2007 Mar 9.

PMID:
17357048
7.

Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus.

Rabatić S, Gagro A, Lokar-Kolbas R, Krsulović-Hresić V, Vrtar Z, Popow-Kraupp T, Drazenović V, Mlinarić-Galinović G.

J Infect Dis. 1997 Jan;175(1):32-7.

PMID:
8985193
8.

The pathogenesis of respiratory syncytial virus disease in childhood.

McNamara PS, Smyth RL.

Br Med Bull. 2002;61:13-28. Review.

PMID:
11997296
9.

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.

Shinoff JJ, O'Brien KL, Thumar B, Shaw JB, Reid R, Hua W, Santosham M, Karron RA.

J Infect Dis. 2008 Oct 1;198(7):1007-15. doi: 10.1086/591460.

PMID:
18702606
10.

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation.

Wang H, Su Z, Schwarze J.

Thorax. 2009 Apr;64(4):283-90. doi: 10.1136/thx.2007.094870. Epub 2008 Aug 18.

11.
12.

Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.

Reed JL, Brewah YA, Delaney T, Welliver T, Burwell T, Benjamin E, Kuta E, Kozhich A, McKinney L, Suzich J, Kiener PA, Avendano L, Velozo L, Humbles A, Welliver RC Sr, Coyle AJ.

J Infect Dis. 2008 Dec 15;198(12):1783-93. doi: 10.1086/593173.

PMID:
18980502
13.

Innate immunity in respiratory syncytial virus bronchiolitis.

Smyth RL.

Exp Lung Res. 2007 Dec;33(10):543-7. Review.

PMID:
18075829
14.

Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.

McNamara PS, Flanagan BF, Hart CA, Smyth RL.

J Infect Dis. 2005 Apr 15;191(8):1225-32. Epub 2005 Mar 14.

PMID:
15776367
15.

Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Gagro A, Tominac M, Krsulović-Hresić V, Baće A, Matić M, Drazenović V, Mlinarić-Galinović G, Kosor E, Gotovac K, Bolanca I, Batinica S, Rabatić S.

Clin Exp Immunol. 2004 Feb;135(2):267-72.

16.

The histopathology of fatal untreated human respiratory syncytial virus infection.

Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS.

Mod Pathol. 2007 Jan;20(1):108-19. Epub 2006 Nov 24.

17.

Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.

Moore ML, Chi MH, Zhou W, Goleniewska K, O'Neal JF, Higginbotham JN, Peebles RS Jr.

J Immunol. 2007 Mar 1;178(5):2651-4.

18.

IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

Dodd JS, Lum E, Goulding J, Muir R, Van Snick J, Openshaw PJ.

J Immunol. 2009 Dec 1;183(11):7006-13. doi: 10.4049/jimmunol.0900085. Epub 2009 Nov 13.

19.

The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Tregoning JS, Yamaguchi Y, Harker J, Wang B, Openshaw PJ.

J Virol. 2008 Apr;82(8):4115-24. doi: 10.1128/JVI.02313-07. Epub 2008 Feb 13.

20.

Supplemental Content

Support Center